BR0114031A - Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina - Google Patents

Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina

Info

Publication number
BR0114031A
BR0114031A BR0114031-0A BR0114031A BR0114031A BR 0114031 A BR0114031 A BR 0114031A BR 0114031 A BR0114031 A BR 0114031A BR 0114031 A BR0114031 A BR 0114031A
Authority
BR
Brazil
Prior art keywords
olanzapine
hydrates
preparation
conversion
crystalline forms
Prior art date
Application number
BR0114031-0A
Other languages
English (en)
Inventor
Buchi Reddy Reguri
Ramesh Chakka
Robert Koprowaski
Original Assignee
Reddy S Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy S Lab Ltd filed Critical Reddy S Lab Ltd
Publication of BR0114031A publication Critical patent/BR0114031A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE HIDRATOS DE OLANZAPINA E SUA CONVERSãO EM FORMAS CRISTALINAS DE OLANZAPINA". A presente invenção refere-se a um método para a preparação de hidratos de 2-metil-4-(4-metil-1-piperazinil)-10H-tieno[2,3-b][1,5]-benzodiazepina (aqui doravante referida como OLANZAPINA). A presente invenção refere-se também a um processo para a conversão destes hidratos em uma forma cristalina de OLANZAPINA referida como Forma 1. A presente invenção refere-se também a um método para converter a Forma 2 de OLANZAPINA na Forma 1.
BR0114031-0A 2000-08-31 2001-03-07 Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina BR0114031A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN709CH2000 2000-08-31
IN711CH2000 2000-08-31
PCT/US2001/007258 WO2002018390A1 (en) 2000-08-31 2001-03-07 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Publications (1)

Publication Number Publication Date
BR0114031A true BR0114031A (pt) 2003-09-09

Family

ID=26324874

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114031-0A BR0114031A (pt) 2000-08-31 2001-03-07 Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina

Country Status (12)

Country Link
EP (1) EP1313742A1 (pt)
JP (1) JP2004507548A (pt)
AU (1) AU2001243475A1 (pt)
BR (1) BR0114031A (pt)
CA (1) CA2420987A1 (pt)
CZ (1) CZ2003566A3 (pt)
HU (1) HUP0300875A3 (pt)
IL (1) IL154688A0 (pt)
NO (1) NO20030926L (pt)
RU (1) RU2003108745A (pt)
SK (1) SK2502003A3 (pt)
WO (1) WO2002018390A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037903A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
WO2003091260A1 (en) * 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
WO2003090730A1 (en) * 2002-04-25 2003-11-06 Generics [Uk] Limited Novel crystalline forms of celecoxib and other compounds
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
DE60336226D1 (de) 2002-05-31 2011-04-14 Sandoz Ag Verfahren zur herstellung von olanzapin form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
PL202856B1 (pl) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
EP1611139B1 (en) 2003-12-22 2008-06-04 Teva Pharmaceutical Industries Ltd. Methods of preparing olanzapine
WO2005070937A1 (en) * 2004-01-27 2005-08-04 Synthon B.V. A process for making olanzapine in a polymorph form i
EP1709053B1 (en) 2004-01-27 2011-04-06 Synthon B.V. Stable salts of olanzapine
EP1716154A1 (en) * 2004-02-19 2006-11-02 Neuland Laboratories Ltd Process for the preparation of olanzapine form 1 useful as antipsychotic drug
WO2005107375A2 (en) * 2004-05-06 2005-11-17 Matrix Laboratories Ltd Process for the preparation of olanzapine form-i
US20080009481A1 (en) * 2004-07-14 2008-01-10 Shasun Chemicals And Drugs Limited Process For Making Form I Of Olanzapine
CA2576862C (en) 2004-07-14 2012-09-11 Jubilant Organosys Limited A process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2,3-b][1,5]benzodiazepine
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
WO2006025065A1 (en) * 2004-08-31 2006-03-09 Lee Pharma Private Limited A process for the preparation of anhydrous olanzopine hydrochloride of form-1
ES2303462B1 (es) * 2004-09-06 2009-06-05 Shasun Chemicals And Drugs Limited Nuevo procedimiento para la preparacion de una forma polimorfica i de olanzapina farmaceuticamente pura.
PL1838716T3 (pl) * 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
AR053562A1 (es) * 2005-03-21 2007-05-09 Reddys Lab Ltd Dr Proceso para la preparacion de la forma i cristalina de olanzapina
HUP0501046A2 (en) * 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
PL381564A1 (pl) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny
EP2185566A2 (en) * 2007-05-15 2010-05-19 Generics Ýuk¨Limited Process for the purification of olanzapine
EP2292624A1 (en) 2009-07-20 2011-03-09 LEK Pharmaceuticals d.d. Process for the purification of olanzapine
CN102093386B (zh) * 2011-01-05 2016-06-01 浙江华海药业股份有限公司 一种制备奥兰扎平晶型ⅱ的方法
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法
PL3466934T3 (pl) 2016-05-31 2024-06-10 Taiho Pharmaceutical Co., Ltd. Związki sulfonoamidowe lub ich sól jako inhibitory reduktazy rybonukleotydowej do leczenia nowotworu
MA51224A (fr) 2017-11-29 2020-10-07 Taiho Pharmaceutical Co Ltd Composés de sulfonamide et leur utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
HU226167B1 (hu) * 1996-09-23 2008-05-28 Lilly Co Eli Olanzapin-dihidrát D, elõállítása és az azt tartalmazó gyógyszerkészítmények
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine

Also Published As

Publication number Publication date
AU2001243475A1 (en) 2002-03-13
IL154688A0 (en) 2003-09-17
CZ2003566A3 (cs) 2004-01-14
SK2502003A3 (en) 2004-03-02
JP2004507548A (ja) 2004-03-11
HUP0300875A2 (hu) 2003-12-29
HUP0300875A3 (en) 2005-09-28
WO2002018390A1 (en) 2002-03-07
NO20030926L (no) 2003-04-24
CA2420987A1 (en) 2002-03-07
EP1313742A1 (en) 2003-05-28
RU2003108745A (ru) 2005-01-10
NO20030926D0 (no) 2003-02-27

Similar Documents

Publication Publication Date Title
BR0114031A (pt) Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina
SI1513846T1 (sl) Postopek za pripravo olanzapina form I
CO5040084A1 (es) Forma polimorfa del hidrogenosulfato de clopidogrel
IS7319A (is) Fjölgervingar klópídógrelvetnissúlfats
DE60228926D1 (de) Sekundärbatterie mit nichtwässrigen Elektrolyten und Verfahren zu ihrer Herstellung
CO4900057A1 (es) Dihidrato d de olanzapina
MX2008013724A (es) Proceso para la preparacion de formas polimorficas de hidrogeno sulfato clopidrogel.
SV1997000081A (es) Intermediantes y procedimiento para obtener olanzapina ref. x- 10986t
NZ510208A (en) Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) pamoate salt
BR0305100A (pt) Processo para a preparação de olanzapina
ID23578A (id) Badan berwarna yang dibakar sampai berwarna merah coklat, proses untuk pembuatannya dan penggunaannya
HU0301082D0 (en) Novel polymorphous forms of olanzapine hydrochloride
WO2005090359A3 (en) Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2, 3-b][1,5]benzodiazepine and salts thereof
PE20030281A1 (es) Formulacion liofilizada de 2-metil-tieno-benzodiazepina
IL137366A0 (en) A method for increasing the fertilizing capability of sperm cells
WO2003037903A8 (en) Olanzapine dihydrate-ii a process for its preparation and use thereof
IL192825A0 (en) A PROCESS FOR THE PREPARATION OF POLYMORPH FORM I OF (S)-(+)-METHYL-ßé?- (2-CHLOROPHENYL)-6,7-DYHIDRO-THIENO-[3,2-C]PYRIDINE-5(4H)-ACETATE HYDROGEN SULFATE
PL356668A1 (en) Novel substituted pyrazolo[4,3-e
AR052767A1 (es) Un procedimeinto para producir 2-metil-4-(4 metil-1-piperizanil)-10h-tieno(2,3-b)(1,5) benzodiazepina en forma pura
ECSP961694A (es) Procedimeinto para preparar olanzapina (caso x - 9992m)
ID25705A (id) Proses pembuatan 8-siklopentil-6-etil-3-[tersubstitusi]-5,8-dihidro-4h-1 3a 8-pentaaza-as-indasena dan senyawa-senyawa antaranya yang berguna
HU0700809D0 (en) Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate
EP1293497A4 (en) PROCESS FOR PRODUCING CALCIUM PENTOTHENATE
MXPA03008970A (es) Procedimiento para la preparacion de 6-aril-4h-s-triazolo [3,4-c]-tieno [2,3-e]-1,4-diacepinas.
UA86772C2 (en) Process for the preparation of the polymorph form of methyl (s)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS.